List of Excipients in API cyclobenzaprine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cyclobenzaprine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | DIETHYL PHTHALATE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | ETHYLCELLULOSE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C BLUE NO. 1 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C BLUE NO. 2 | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C RED NO. 40 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing cyclobenzaprine
Detailed excipient profiles for cyclobenzaprine
Excipient focus: ALCOHOL
cyclobenzaprine drug variants containing ALCOHOL
cyclobenzaprine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
cyclobenzaprine drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | cyclobenzaprine hydrochloride | 66116-527 |
| RedPharm Drug Inc | cyclobenzaprine hydrochloride | 67296-0106 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
cyclobenzaprine drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
cyclobenzaprine drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
cyclobenzaprine drug variants containing ANHYDROUS LACTOSE
cyclobenzaprine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
cyclobenzaprine drug variants containing BUTYL ALCOHOL
cyclobenzaprine drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
cyclobenzaprine drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
cyclobenzaprine drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
cyclobenzaprine drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | cyclobenzaprine hydrochloride | 50436-0950 |
| Quality Care Products LLC | cyclobenzaprine hydrochloride | 55700-726 |
| Casper Pharma LLC | cyclobenzaprine hydrochloride | 70199-014 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
cyclobenzaprine drug variants containing CARNAUBA WAX
cyclobenzaprine drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
cyclobenzaprine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| DIRECTRX | cyclobenzaprine hci | 61919-681 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| Teva Pharmaceuticals USA Inc | cyclobenzaprine hydrochloride | 0093-1920 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77492
cyclobenzaprine drug variants containing CI 77492
cyclobenzaprine drug variants not containing CI 77492
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
cyclobenzaprine drug variants containing CI 77891
cyclobenzaprine drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
cyclobenzaprine drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | cyclobenzaprine hydrochloride | 16590-544 |
| STAT Rx USA LLC | cyclobenzaprine hydrochloride | 42549-641 |
| State of Florida DOH Central Pharmacy | cyclobenzaprine hydrochloride | 53808-1039 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
cyclobenzaprine drug variants containing CROSCARMELLOSE SODIUM
cyclobenzaprine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
cyclobenzaprine drug variants containing CROSPOVIDONE
cyclobenzaprine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
cyclobenzaprine drug variants containing D&C YELLOW NO. 10
cyclobenzaprine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
cyclobenzaprine drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | cyclobenzaprine hydrochloride | 64980-655 |
| Graviti Pharmaceuticals Private Limited | cyclobenzaprine | 69844-109 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
cyclobenzaprine drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
cyclobenzaprine drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
cyclobenzaprine drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Tonix Medicines Inc | cyclobenzaprine hydrochloride | 70792-102 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYL PHTHALATE
cyclobenzaprine drug variants containing DIETHYL PHTHALATE
cyclobenzaprine drug variants not containing DIETHYL PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
cyclobenzaprine drug variants containing ETHYLCELLULOSE
cyclobenzaprine drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
cyclobenzaprine drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | cyclobenzaprine hydrochloride | 16590-596 |
| Rebel Distributors Corp | cyclobenzaprine hydrochloride | 21695-723 |
| Rebel Distributors Corp | cyclobenzaprine hydrochloride | 21695-953 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cyclobenzaprine drug variants containing FD&C BLUE NO. 1
cyclobenzaprine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
cyclobenzaprine drug variants containing FD&C BLUE NO. 2
cyclobenzaprine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
cyclobenzaprine drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 62332-646 |
| Rising Pharma Holdings Inc | cyclobenzaprine hydrochloride | 64980-655 |
| Graviti Pharmaceuticals Private Limited | cyclobenzaprine | 69844-109 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
cyclobenzaprine drug variants containing FD&C GREEN NO. 3
cyclobenzaprine drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
cyclobenzaprine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| Teva Pharmaceuticals USA Inc | cyclobenzaprine hydrochloride | 0093-1920 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
cyclobenzaprine drug variants containing FD&C YELLOW NO. 6
cyclobenzaprine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
cyclobenzaprine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| RPK Pharmaceuticals Inc | cyclobenzaprine | 53002-0521 |
| DIRECT RX | cyclobenzaprine | 61919-305 |
| RedPharm Drug Inc | cyclobenzaprine | 67296-1728 |
| Cipla USA Inc | cyclobenzaprine | 69097-845 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
cyclobenzaprine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| Graviti Pharmaceuticals Private Limited | cyclobenzaprine | 69844-109 |
| DIRECTRX | cyclobenzaprine hci | 61919-681 |
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
cyclobenzaprine drug variants containing FERROSOFERRIC OXIDE
cyclobenzaprine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cyclobenzaprine drug variants containing GELATIN
cyclobenzaprine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
cyclobenzaprine drug variants containing HYDROXYPROPYL CELLULOSE
cyclobenzaprine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
cyclobenzaprine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| Clinical Solutions Wholesale LLC | cyclobenzaprine | 58118-0846 |
| Proficient Rx LP | cyclobenzaprine | 63187-812 |
| Preferred Pharmaceuticals Inc | cyclobenzaprine | 68788-7398 |
| DIRECTRX | cyclobenzaprine hci | 61919-681 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
cyclobenzaprine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | cyclobenzaprine hydrochloride | 69336-104 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
cyclobenzaprine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Northwind Pharmaceuticals | cyclobenzaprine | 51655-973 |
| RPK Pharmaceuticals Inc | cyclobenzaprine | 53002-0521 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
cyclobenzaprine drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 16070722
cyclobenzaprine drug variants containing HYPROMELLOSE ACETATE SUCCINATE 16070722
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 16070722
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
cyclobenzaprine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| DIRECT RX | cyclobenzaprine | 61919-305 |
| Coupler Enterprises | cyclobenzaprine | 67046-148 |
| NuCare Pharmaceuticals Inc | cyclobenzaprine | 68071-3150 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| Northwind Pharmaceuticals | cyclobenzaprine | 51655-973 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
cyclobenzaprine drug variants containing ISOPROPYL ALCOHOL
cyclobenzaprine drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
cyclobenzaprine drug variants containing LACTOSE
cyclobenzaprine drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
cyclobenzaprine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
cyclobenzaprine drug variants containing LECITHIN, SOYBEAN
cyclobenzaprine drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cyclobenzaprine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
cyclobenzaprine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Tonix Medicines Inc | cyclobenzaprine hydrochloride | 70792-102 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
cyclobenzaprine drug variants containing METHYL ALCOHOL
cyclobenzaprine drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
cyclobenzaprine drug variants containing MICROCRYSTALLINE CELLULOSE 102
cyclobenzaprine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
cyclobenzaprine drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 0378-0771 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOL
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | cyclobenzaprine hydrochloride | 69336-104 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1450
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 62332-646 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOL 8000
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
cyclobenzaprine drug variants containing POLYETHYLENE GLYCOLS
cyclobenzaprine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
cyclobenzaprine drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| Northwind Pharmaceuticals | cyclobenzaprine | 51655-973 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| RPK Pharmaceuticals Inc | cyclobenzaprine | 53002-0521 |
| DIRECT RX | cyclobenzaprine | 61919-305 |
| RedPharm Drug Inc | cyclobenzaprine | 67296-1728 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
cyclobenzaprine drug variants containing POLYVINYL ALCOHOL
cyclobenzaprine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
cyclobenzaprine drug variants containing POTASSIUM HYDROXIDE
cyclobenzaprine drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
cyclobenzaprine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cyclobenzaprine drug variants containing PROPYLENE GLYCOL
cyclobenzaprine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
cyclobenzaprine drug variants containing SHELLAC
cyclobenzaprine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICA
cyclobenzaprine drug variants containing SILICA
cyclobenzaprine drug variants not containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICIFIED MICROCRYSTALLINE CELLULOSE
cyclobenzaprine drug variants containing SILICIFIED MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| NuCare Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 68071-3805 |
| NuCare Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 68071-3915 |
| NORTHSTAR RX LLC | cyclobenzaprine hydrochloride | 72603-310 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing SILICIFIED MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
cyclobenzaprine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECTRX | cyclobenzaprine hci | 61919-681 |
| Direct_Rx | cyclobenzaprine hcl | 61919-901 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| Teva Pharmaceuticals USA Inc | cyclobenzaprine hydrochloride | 0093-1920 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
cyclobenzaprine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
cyclobenzaprine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| Mylan Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 0378-0771 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
cyclobenzaprine drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Tonix Medicines Inc | cyclobenzaprine hydrochloride | 70792-102 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
cyclobenzaprine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
cyclobenzaprine drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Medsource Pharmaceuticals | cyclobenzaprine hydrochloride | 45865-685 |
| DIRECT RX | cyclobenzaprine hydrochloride | 61919-025 |
| Ranbaxy Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 63304-214 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
cyclobenzaprine drug variants containing SUCROSE
cyclobenzaprine drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| Unit Dose Services | cyclobenzaprine | 50436-0846 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
cyclobenzaprine drug variants containing TALC
cyclobenzaprine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cyclobenzaprine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
cyclobenzaprine drug variants containing TRIACETIN
cyclobenzaprine drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | cyclobenzaprine | 0615-8084 |
| Macleods Pharmaceuticals Limited | cyclobenzaprine | 33342-272 |
| A-S Medication Solutions | cyclobenzaprine | 50090-3253 |
| AvPAK | cyclobenzaprine | 50268-191 |
| UNIT DOSE SERVICES | cyclobenzaprine | 50436-0401 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
